Dr. Robert W. Buckingham joined PHHS after having previously been appointed as the Jack W. Thompson, M.D. Distinguished Visiting Professor at the University of Michigan-Flint in 2013-14. A Yale graduate, Dr. Buckingham was appointed inaugural Executive Director/Dean of the School of Public Health with the University of Saskatchewan, in 2009. He has authored more than 12 books and many scientific referred papers, with the most recent being a textbook entitled, “A Primer on International Health” published by Allyn & Bacon, and five books on hospice care, including, “Care of the Dying Child” published by the Continuum Publishing Company, which was translated in seven languages.

Dr. Buckingham, helped pioneer the development of the first Hospice in the U.S. and is considered one of the “Founding Fathers” of hospice in North America. He was the first Director of Research of hospice in Connecticut in 1974, and subsequently founded another 81 hospice programs worldwide, including a hospice for children afflicted with HIV/AIDS in Thailand. Dr. Buckingham has developed new collaborative research and scholarly exchanged programs with Mahidol University in Thailand, Hawassa University in Ethiopia, as well as the Nelson Mandela Institute of Science and Technology in Arusha, Tanzania and locally, with the Heart and Stroke Foundation of Saskatchewan.

evin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

Biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Head of UNESCO Chair sexual health & Human rights, and Public health professor in Paris Diderot University

Sexual health, Human Rights, HIV, STIs, Brief Sexual Communication, globale approach in sexual education, training of sexuality educator

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Infectious Diseases

Dr. Mandy Hill has acquired a wealth of academic experience in the design, development, and implementation of behavioral research within a clinical setting. Trained as a clinical researcher, Dr. Hill has a documented history of advancing a prevention-based public health agenda within a clinical environment. Her academic portfolio to date has been based on creating a niche of merging public health and emergency medicine. She has published 22 peer reviewed manuscripts, 10 of which she first authored, in diverse areas addressing health disparities among disadvantaged minority populations, coupled with 25 abstracts, 20 presentations and extramural funding support from the Center for Disease Control and Prevention and the National Institutes of Health through the American Psychological Association and Centers for AIDS Research, as well as industry sponsored research. These tangible outcomes attest to her scientific contributions to date. Her primary research focus is HIV/AIDS, STIs, and STDs. In summary, here expertise includes the design, implementation, and analysis of pilot and exploratory studies, randomized clinical trial development and implementation, and integrating public health-based prevention research into routine clinical visits in the emergency department.

HIV/AIDS, STIs, and STDs

Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 400 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier. He is currently Editor-in-Chief of Archives of Virology, Journal of Molecular Recognition and Journal of AIDS & Clinical Research; An Associate Editor of Advances in Virus Research, Frontiers in Immunotherapies and Vaccines, Journal of Immunological Methods, ISRN Immunology and Bionomina.

General virology, Immunochemistry of viruses, viral diagnostics, synthetic peptide vaccines, HIV vaccines, SPR biosensors, viral taxonomy, philosophy of science

Dr. Kimberly A. Parker is an Associate Professor at Texas Womans University in Denton, TX. She has earned a PhD from the University of Georgias College of Public Health, a MPH from the Arnold School of Public Health at the University of South Carolina, and is a Master Certified Health Education Specialist. Dr. Parker conducts qualitative and mixed-methods research on women and minority health issues and currently serves as the Principle Investigator for several research projects. Her primary studies are Be-PrEPared, a curriclum development project to assess the implementation of a multi-strategies intervention to increase knowledge and awareness about PrEP among cis- and trans-women of color, Lend Us Your Voice Project, a qualitative study which examines the lived experience of HIV positive African American women in the South, and the HIV risk assessment study which examines multiple variables associated with contracting HIV, social vulnerabilities, and HIV risk perceptions among African American women. She has also spearheaded several public health curriculum design and evaluation projects related to HIV prevention and womens health issues. Dr. Parker has written several manuscripts on HIV/AIDS, the intersection of race and gender, and minority health issues, and has served as a guest columnist for the Dallas Morning News and The Body. Her research interest includes social sexual factors that influence HIV transmission and health disparities among vulnerable populations.

.

Dr Stef Stienstra is a Strategic and creative development manager in biomedical science, with a parallel career as a reserve commander of the Royal Dutch Navy. For the Dutch Armed Forces he has a responsibility in the counter measures in CBNRe threats and consequence management both in a military and in a civilian (terrorism) context. In his civil career he works internationally as consultant or as scientific supervisory board member for several medical and biotech companies. At this moment for MT-Derm in Berlin (D) developing a novel intradermal vaccination technology, IQ Therapeutics in Groningen (NL) developing therapeutic antibodies against anthrax and orthopox viruses, Hemacon in Düsseldorf (D) developing a field donor blood separation and blood transfusion unit, Infection Control in Eemnes (NL) developing a bio-disinfection system for bioterrorism consequence management and IB Consulting in The Hague (NL) for biodefense projects. He has finished his studies Medicine and Biochemistry in The Netherlands and has extensive practical experience in cell biology, immuno-haematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

CBRN defense, (therapeutic) vaccines, trauma healthcare, blood transfusion, sailing

Timms is Professor of Microbiology and Director of Research at QUT’s Institute of Health and Biomedical Innovation in Brisbane Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. Timms has published over 170 refereed journal papers and is editor of the journal, Pathogens and Disease.

He leads a well established research team of 10 people. His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas.

Kevin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

covert chemical, biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Enric Pedrol is from Fundació Sant Hospital Infectious Diseases, Internal Medicine (General Medicine), Spain

Infectious Disease, Medicine, HIV, Infection, AIDS, Hepatitis C, Liver, Hepatitis Viruses

Daniel Bauer is internationally revered as the Successor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS. Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, he has gracefully triumphed to once again pursing his dreams. He is one the most requested motivational public speakers and entertainers who continues to present highly engaging educational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually (adolescents, healthcare professionals and mainstream communities &audiences at-large) focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. He is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelessly to promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference.

HIV

Charbell Miguel Haddad Kury, a Medical Doctor and Professor of Medicine, graduated from the Medical School of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil in 2003. He is expert in Public Health, from the Medicine School of Campos dos Goytacazes, in 2004. He is Pediatrician infectious disease specialist from the Jesus Hospital, Rio de Janeiro in 2007. He is also a Professor of Pediatrics of the Medicine Schools of Campos dos Goytacazes and the Federal University of Rio de Janeiro, Brazil. He has a Master’s degree in Applied Microbiology and Parasitology from the Fluminense Federal University, in 2013. He is a Pediatrician and Neonatologist of the St. John the Baptist Hospital, Municipality of Macaé, State of Rio de Janeiro, Brazil, since 2005 and Coordinator of Immunization and Health Surveillance of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil, since 2009. He did research on immunization programs, once the municipality of Campos dos Goytacazes implemented the largest immunization program.

Public Health,HIV/AIDS

Hiroshi Ohrui has received Ph.D. degree (1971) from The University of Tokyo. He joined RIKEN (1966), moved to Tohoku University (1881) and then to Yokohama University of Pharmacy (2006). His interest covers Organic Synthesis, Chemical Biology, and Chiral Discrimination.

HIV

Dr. NWAKO Okechukwu Francis had his B.Sc in Applied Microbiology(upper credit ) in 2001 and proceeded to Medical School where he graduated in 2009. In 2012, he obtained his M.Sc( Medical Microbiology) and has completed his Ph.D course work in Medical Microbiology with major in Mycology. He hope to complete his research work by 2016. He obtained his Primary in Internal Medicine in 2010 and became a specialist in Internal Medicine in 2015 from the West Africa College of Physicians. He has published several original articles in international journals and has attended several conferences both locally and internationally including the famous HIV/AIDS 2013 organized by OMICS conferences. He has reviewed many articles for British Journal of Medicine and Medical Research and Journal of AIDS.

HIV

Daniel Bauer is internationally revered as the Successor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS. Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, he has gracefully triumphed to once again pursing his dreams. He is one the most requested motivational public speakers and entertainers who continues to present highly engaging educational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually (adolescents, healthcare professionals and mainstream communities &audiences at-large) focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. He is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelessly to promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference.

HIV

Baran Halina is presently Head of the Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment Mauer, Lower Austria, from 2005-2011 she was the head of Head of the Neurochemical Laboratory Karl Landsteiner Institute Mauer and Head of Neurophysiology, Veterinary Medical University Vienna. In the year 1998-2005, she was Assoc. Prof. at Institute of Pharmacology and Toxicology, Veterinary Medical University Vienna.

HIV

Michelle Moorhouse graduated from Wits University in South Africa, and qualified as a GP anaesthetist. Then, like many of her peers, switched her professional track to the management of HIV. Michelle co-founded Triple M Research, placing Port Elizabeth firmly on the map as one of the first HIV clinical trial centers in the Eastern Cape. Michelle went on to found the HIV journal club in PE, which later became the local chapter of the Southern African HIV Clinicians Society. In 2003 Michelle was awarded an Honorary Clinical Fellowship at the Royal Free Hospital in London. She has also worked in the pharmaceutical industry, holding senior advisory posts at Abbott and Boehringer, she led the UK launch of Tipranavir in 2005, and was medical director at Novartis Vaccines and acting head of HIV therapeutics at GSK. Whilst working in the UK, Michelle earned the respect of many leading internationally renowned HIV clinicians. Michelle returned to South Africa in 2007, where she re-established her general/HIV practice - much to the excitement of a number of patients who started ARV treatment under her management many years earlier! Michelle went on to found a research centre that focused on HIV clinical trials, and also provided principle investigator services to local CROs. Consulting at a local clinic in Motherwelltownship for IYDSA, an Eastern Cape based NPO, signaled a change in Michelle’s career. This branch of public health brought her closer to the other realities of the HIV/AIDS epidemic, providing an opportunity to play a greater part in tackling the disease that she has dedicated her career to so passionately. She later joined full-time, initially as Clinical Advisor, and then Technical Lead Research and Training, proudly contributing to the NGO's rapid growth, rebranding to Beyond Zero, and becoming one of the leading HIV/AIDS focused NPOs in the Eastern Cape. In 2012, Michelle was elected to the inaugural Board of Directors of the Southern African HIV Clinicians Society, devoting much of her time to organisational development, supporting new treatment guidelines, conceptualising a new corporate membership programme, and of course, a little bit of activism against HIV/AIDS quackery(!), and supporting the biennial Clinicians Society Conference She is also member of the Editorial Boards of HIV Nursing Matters magazine, and the MRC AfroAIDSinfo portal, as well as a member of MedDigital Expert Panel and HIV Physicians Panel. In September 2014, Michelle took up an exciting position as Senior Clinician at Wits Reproductive Health and HIV Institute (RHI), and relocated to Johannesburg. In this role, she is actively engaged in clinical work, research and teaching, as well as sitting on National HIV guideline committees, advising the National Department of Health, training the master trainers of the 9 provinces on new guidelines, to mention a few of her responsibilities. Michelle has recently been appointed to the national Third Line ART Committee, which reviews patients failing their second line regimen (or beyond) and advises regarding their further management for the National Department of Health. Michelle is particularly interested in ARV resistance, helping HIV affected couples have healthy babies, and sharing her HIV knowledge through talks, workshops and training.

HIV

Bernardino Geraldo Alves Souto was graduated in medicine at Federal University of Juiz de Fora, Minas Gerais, Brazil, in 1987. Received his master's degree in 2002 and Ph.D. in 2006, in Infectious Diseases and Tropical Medicine, at Federal University of Minas Gerais, Brazil. Specialist in Intensive Care Medicine, Clinical Medicine/Internal Medicine and Epidemiology. Professor of the Department of Medicine of the Federal University of São Carlos, São Paulo, Brazil. Practices general integral medicine and is attending physician at Specialized Care Service in STD/HIV/Aids of São Carlos, São Paulo, Brazil. As researcher, mainly investigates the epidemiology of HIV infection, and the psychological and social issues related to people living with this virus.

HIV/AIDS

Charbell Miguel Haddad Kury, a Medical Doctor and Professor of Medicine, graduated from the Medical School of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil in 2003. He is expert in Public Health, from the Medicine School of Campos dos Goytacazes, in 2004. He is Pediatrician infectious disease specialist from the Jesus Hospital, Rio de Janeiro in 2007. He is also a Professor of Pediatrics of the Medicine Schools of Campos dos Goytacazes and the Federal University of Rio de Janeiro, Brazil. He has a Master degree in applied microbiology and parasitology from the Fluminense Federal University, in 2013. He is a Pediatrician and Neonatologist of the St. John the Baptist hospital, municipality of Macaé, State of Rio de Janeiro, Brazil, since 2005 and Coordinator of Immunization and Health surveillance of the municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil, since 2009. He did research on immunization programs, once the municipality of Campos dos Goytacazes implemented the largest immunization program in early 2009.

HIV

D K Agarwal has 24 years of experience in the field of Nephrology including specialization in renal transplant, hemodialysis, CAPD and all kidney problems and diseases along with critical kidney patients with emergency management. He is well experienced in handling kidney patients with diabetes and hypertension and other diseases. He is also well experienced in renal transplantation in HIV patients. He worked as Senior Consultant, Nephrologist in various institutions of National and International repute like Nizam’s Institute of Medical Sciences, Hyderabad, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow etc. He isexperienced at division of Nephrology, Department of Medicine, University of Missouri, School of Medicine, Columbia, USA. At present he is working as Senior Consultant in Nephrology and renal transplant, Indraprastha Apollo Hospitals, New Delhi, India.

HIV/AIDS

Nwako Okechukwu Francis is a registrar in medicine department of Federal medical centre Owerri and a medical microbiologist with about 3 years teaching experience. He obtained B.Sc in microbiology in 2001, MBBS in 2009, primary fellowship in 2010 and M.Sc in medical microbiology in 2012. He has done some published work Nigeria. His on the job experience in the care and management of HIV positive clients in a resource poor setting ignited his interest in HIV medicine. His keen interest is in opportunistic infections in HIV/AIDS. He has applied to study Infection and Immunity in Ph.D in Nigeria. He is a member of NMA, associate fellow of WACP, associate fellow of NPMC, member NSM and NARD.

HIV

Huynh has received Ph.D. in Bio-Organic chemistry from the University of Tokyo, Japan, in 1979. He was chemist at Nippon Kayaku Chemical Co. Japan and postdoc with School of Pharmacy, Purdue University. He worked with Stanford Research Institute International, in Bio-Organic Chemistry Department, and Applied Biosystems Inc., in R&D Department. Huynh was senior manager in anti-HIV research at Triplex Pharmaceuticals Inc., and molecular diagnostic research at Gen-Probe Inc. From 2009, he worked as CSO of Genomeplex Research Institute, Inc. for manufacturing of Real Time PCR for HIV-1 virus. He has more than 200 presentations, publications and product developments with companies.

Andrew D. Badley, M.D., was born in Sydney, Nova Scotia, Canada. He earned his B.S. degree in 1985 and M.D. degree in 1990, both from Dalhousie University in Halifax, Nova Scotia. After completing residency training in internal medicine at Mayo Clinic in Rochester, Minn., in 1994, Dr. Badley completed further training at Mayo Clinic as a clinician investigator trainee in the Division of Infectious Diseases in 1997. During his training, Dr. Badley received the Dr. J. Geraci Award for Excellence in Infectious Diseases from Mayo Clinic in June 1997, as well as the Young Investigator Award from the Interscience Conference on Antimicrobial Agents and Chemotherapy and American Society for Microbiology (ICAAC/ASM) in September 1997. Dr. Badley joined the staff of Ottawa Hospital in Ottawa, Ontario, Canada, in 1997 as an assistant professor in the Division of Infectious Diseases and in 2002 was promoted to an associate professor. In 2002, Dr. Badley returned to Mayo Clinic in Rochester as a consultant in the Division of Infectious Diseases and brought with him his successful research program. At Mayo Clinic, Dr. Badley is currently a professor of medicine and consultant in the Division of Infectious Diseases; associate director of the Research Resources component of the Center for Translational Science Activities; and theme leader for infectious disease research on the Research Development Council, an internal Mayo committee.

virus-host interactions, in particular how viral proteins modify the host immune response and/or cell survival.

erthold Kepplinger was medical director of the neuro-rehabilitation Wall Amstetten and the Neuro Rehabilitation and Pain Wall Amstetten and Head of acute Logie and Stroke Unit. In the past 10 years, he worked as medical director of the State Hospital Wall Amstetten.

Baran Halina is presently Head of the Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment Mauer, Lower Austria, From 2005 - 2011 she was the head of Head of the Neurochemical Laboratory Karl Landsteiner Institute Mauer and Head of Neurophysiology, Veterinary Medical University Vienna.

Francois Villinger, DVM, PhD, Chief of the Yerkes Division of Pathology, graduated from the University of Zurich, Switzerland. The primary research interests of Dr. Villinger and his lab team are modeling human infectious diseases in relevant nonhuman primate models, particularly for those diseases without other models and those that do not reproduce human pathogenesis. These diseases include HIV/AIDS as well as infection models of XMRV, dengue fever and listeria. As Chief of the Division of Pathology, Dr. Villinger oversees the administrative functions of the division. This entails oversight of the administrative staff, approving grant submissions by division faculty and trainees, ensuring appropriate allocation of division resources and mentoring junior faculty. Dr. Villinger is involved in reporting division research activities to the National Center for Research Resources (NCRR) and preparing progress and plan descriptions of division research activities for the Yerkes Research Center’s P51 base grant renewal. Dr. Villinger also serves as the liaison between division staff and the Yerkes administration, and advises the director on issues related to the scientific mission of the Center. In addition, the Villinger lab runs a NCRR-funded resource that provides nonhuman primate specific immunomodulatory reagents, such as recombinant cytokines and soluble forms of immune-receptors, to investigators on a national and international level. The Yerkes research center provides 60 samples annually.

Immunology of infectious diseases, AIDS and resource for nonhuman primate immune reagents.

Stela Halichidis is a director in the Department of Medical Faculty at Ovidius University, Romania. She was head of HIV department, Constanta, Romania. She has published various papers related to HIV, and is member in many national and international medical associations (ESCMID, ESC, Romanian Infectious Diseases Society, Balcanic Medical Society, Romanian Parasitology Society, International AIDS Society, and Balkan Environmental Association).

Daniel Bauer is internationally revered as theSuccessor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS.Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, Daniel Bauer has gracefully triumphed to once again pursing his dreams. Daniel Bauer is one the most requested motivational public speakers and entertainers who continues to present highly engagingeducational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually(adolescents, healthcare professionals and mainstream communities &audiences at-large)focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. Daniel Bauer is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelesslyto promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City’s off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference. And if that is not enough of an iconic ship of accomplishment, Bauer has also held prime consulting and contractual professional positions in the fields of government, education, special event planning, fund raising and youth development programming to promote healthy-living and equality for all walks of life while continuing to create waves, inspire hope and promote positive change among our communities to unite global synergistic efforts in the fight against HIV/AIDS.

Design and analysis of clinical trials for vaccines against infectious diseases, Statistical methods in immunological assay validation and evaluation, Statistical methods in equivalence testing, Immune correlates of protection and Meta-analysis.

Dr. Aboul-Ata Elnady ABOUL-ATA, Professor Dr. of Plant virology, who was born on Mar.22nd 1948 in Sharkia, Egypt, is the president of ArSV (Arab Society for Virology) in 2013. He was formerly Department Head of Plant Virus and Phytoplasma Research, Plant Pathology Research Institute at Agricultural Research Center, Giza, Egypt for 3 years (2003-2006), and Head of Molecular laboratory at Plant Virus and Phytoplasma Res. from Sep. 2005 up to now. Dr. Aboul-Ata is the author of more than 40 scientific papers in different approaches like gene silencing, sequencing of viral genes. He lead an Egyptian research group (human virologists and molecular biologists) for a Swedish-funded project on Plant-based vaccine against HSV-2 in collaboration with Gothenburg University, Sweden throughout 2007-2010. He also lead a MERC project on detection of cereal viruses for prevention through quarantine system in Middle East countries (Egypt, Jordan, Israel and Palestine) throughout 2008-2011. He is in charge of nanoscience introduction to the domain of plant virology at Plant Pathology Research Institute. He is chosen for general-, scientific- and organizing-committee member for the First and 2nd Conference of Virology, which was organized by ESV at 2004 and 2008, Cairo, Egypt. He has also been chosen to be International Advisory-committee member for the 2nd Green revolution in India that is organized from 2-5 July, 2009. He is an evaluation-committee member for promotion to higher scientific position i.e. Assoc. Professorship and Professorship at Institute of Plant Pathology, ARC, Egypt 2008 up to now.

Dr. Nafees Ahmad received his B. S.(Hons) in Chemistry and M. S. in Biochemistry from one of the prestigious central universities in India, The Aligarh Muslim University. He then joined another renowned research institute, The Central Drug Research Institute, Lucknow, India, from where he earned his Ph.D. in 1983. Dr. Ahmad did his Postdoctoral Fellowship at the National Institutes of Health (NIH), Bethesda, Maryland, USA from 1985-1990 in the Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases. His research primarily focused on the regulation of HIV-1 gene expression and replication, especially the role of HIV-1 regulatory and accessory proteins in HIV-1 replication and biology. In 1990, a group of scientists from the NIH, including Dr. Ahmad moved to J.N. Gamble Institute of Medical Research, Cincinnati, Ohio to start a new program on Molecular Virology, including his own independent research program on molecular mechanisms of HIV-1 mother-to-infant transmission. In 1994, Dr. Ahmad joined the University of Arizona College of Medicine’s Department of Microbiology and Immunology (now Immunobiology). His research involves understanding the molecular mechanisms of differential HIV infection in infants and adults and vertical transmission and pathogenesis. In addition, he directs the Immunity and Infection block of the medical curriculum of the College of Medicine.

Dr. Ramendra K. Singh, an Associate Professor of Chemistry at the University of Allahabad, India, is Director of the Nucleic Acids Chemistry and Antiviral Research laboratory and is member of several national committees. He has several awards/fellowships, like ISCA Young Scientists Award, INSA Visiting Fellowship, UNESCO Fellowship, XVI IUBMB Fellowship, Jawaharlal Nehru Visiting Fellowship, Post-Doc Fellowship, Govt of Japan, INSA International Exchange Fellowship and Fulbright-Nehru Senior Research Fellowship to his credit. His research interest lies in computer-aided designing and development of antiviral molecules against HIV, HPV and JEV and developing fluorescent oligonucleotides for use in the field of molecular biology and diagnostics. He has about a dozen anti-HIV and half-a-dozen anti-JEV compounds under patent processing. Dr. Singh is on editorial board of several international journals and referee to more than a dozen journals.

Heather initially completed her BS in Biology at the University of North Carolina, Chapel Hill, moving on to study for an MD/PhD in Molecular and Cell Biology at Tulane University, New Orleans, qualifying in 1999. She currently is a Senior Scientist at Seattle Biomed and a Senior Lecturer at University of Cape Town. She also holds an affiliate Associate Professorship at University of Washington’s Department of Global Health.

prevention of HIV acquisition in children and adolescents and immunology thereof.